Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 8Recruiting 4Active not recruiting 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 1Odontogenic Cysts 1Melanoma 1Lung Neoplasms 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Radionuclide Imaging × Clear all
NCT06688851 2026-04-24

Patient Specific Implants (PSIs) for the Decompression of Odontogenic Cysts

Semmelweis University

Recruiting
20 enrolled

Odontogenic Cysts

NCT06003556 2025-07-04

P-GAP

University of Alberta

Phase 2 Recruiting
138 enrolled
Genitourinary

Prostatic Neoplasms

NCT06666790 2024-10-31

DermaSensor Postmarket Surveillance Study

DermaSensor, Inc.

Phase NA Recruiting
396 enrolled
Dermatologic

Melanoma

NCT06626178 2024-10-03

ARIA

Scientific Institute San Raffaele

Phase NA Recruiting
2,840 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡